抗纤溶药物在整形外科中的应用:当前实践与未来方向
本文通过系统综述PubMed、Cochrane和Google Scholar数据库,纳入33项研究共1823例接受整形手术的患者,其中使用氨甲环酸1328例、ε-氨基己酸495例。结论认为氨甲环酸和ε-氨基己酸广泛用于颅颌面和正颌手术以减少失血和输血需求,不增加不良事件风险;静脉给药最常用,局部制剂疗效相似但全身分布减少;氨甲环酸在美容手术和烧伤护理中也有前景。
要点
- 氨甲环酸和ε-氨基己酸广泛用于颅颌面和正颌手术减少失血和输血,不增加不良事件风险。
- 静脉给药最常用,局部制剂疗效相似但全身分布减少。
- 氨甲环酸在美容手术和烧伤护理中因安全性好、减少失血、改善术野、减轻水肿和瘀斑而有前景。
核心结论
- 氨甲环酸和ε-氨基己酸广泛用于颅颌面和正颌手术以减少失血和输血需求,不增加不良事件风险。
- 静脉给药最常用,局部制剂疗效相似但全身分布减少。
- 氨甲环酸在美容手术和烧伤护理中因安全性好、减少失血、改善术野、减轻水肿和瘀斑而有前景。
- 需在烧伤护理、美容手术和显微外科领域进一步研究以标准化临床使用方案。
研究设计与样本
- 系统综述,检索PubMed、Cochrane和Google Scholar数据库,纳入33项研究,共1823例接受整形手术的患者。
主要发现
- 纳入33项研究,共1823例患者,其中使用氨甲环酸1328例,使用ε-氨基己酸495例。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Prevention of blood loss is a chief consideration in plastic and reconstructive surgery. The antifibrinolytic drugs tranexamic acid and ε-aminocaproic acid have emerged as promising agents to reduce both perioperative blood loss and transfusion requirements. However, published reports in the plastic surgery literature are lacking. The authors sought to summarize the current knowledge of the use of antifibrinolytics in plastic surgery by reviewing the existing literature for clinical outcomes and recommendations. METHODS: A systematic review of the PubMed, Cochrane, and Google Scholar databases was conducted for publications examining the use of antifibrinolytics in plastic surgery. Studies were abstracted for procedure type, antifibrinolytic dose, time and mode of administration, blood loss, transfusion requirements, and complications. RESULTS: Thirty-three studies were deemed eligible for inclusion, comprising a total of 1823 patients undergoing plastic surgical procedures with tranexamic acid (n = 1328) and/or ε-aminocaproic acid (n = 495). CONCLUSIONS: Tranexamic acid and ε-aminocaproic acid are widely used to reduce blood loss and transfusion requirements in craniofacial and orthognathic surgery, without an increased risk of adverse events. Intravenous administration is most commonly used, although topical formulations show similar efficacy with a reduced systemic distribution. Tranexamic acid has also emerged as a promising agent in aesthetic surgery and burn care, due to its favorable safety profile and role in reducing blood loss, achieving an improved surgical field, and reducing edema and ecchymosis. Further investigation of these agents in the fields of burn care, aesthetic surgery, and microsurgery is warranted to standardize protocols for clinical use.
引用
- Brown S, Yao A, Taub PJ, et al. Antifibrinolytic Agents in Plastic Surgery: Current Practices and Future Directions. Plast Reconstr Surg. 2018. PMID: 29794717. doi:10.1097/PRS.0000000000004421
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。